CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy

Seung Hyeun Lee, Sue In Choi, Ji Sung Lee, Chul Hwan Kim, Won Jai Jung, Eun Joo Lee, Kyung Hoon Min, Gyu Young Hur, Seung Heon Lee, Sung Yong Lee, Je Hyeong Kim, Sang Yeub Lee, Chol Shin, Jae Jeong Shim, Kyung Ho Kang, Kwang Ho In

Cancer Research and Treatment. 2017;49(1):141-149. Published online 2016 May 18 DOI: https://doi.org/10.4143/crt.2016.133

Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy

Cancer Research and Treatment. 2017;49(1):141-149

Link1

Link2 Link3

Patients Treated With Platinum-Doublet Chemotherapy for Advanced Non–Small-Cell Lung Cancer Have Inferior Outcomes If Previously Treated With Platinum-based Chemoradiation

Ashvin Paramanathan, Benjamin Solomon, Marnie Collins, Michael Franco, Sarah Kofoed, Heather Francis, David Ball, Linda Mileshkin

Clinical Lung Cancer. 2013;14(5):508-512

Link1 Link2

P2.03b-040 NANOG Predicts Poor Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy

Seung Hyeun Lee, Myung Jae Park, So Young Park, Kwang Ho In, Chul Hwan Kim

Journal of Thoracic Oncology. 2017;12(1):S959-S960

Link1 Link2

Phase 2 study of cryptophycin 52 ( LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer

M Edelman

Lung Cancer. 2003;39(2):197-199

Link1 Link2

DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy

A.S. Tsao

Yearbook of Oncology. 2012;2012:169-170

Link1 Link2

Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy

Hyun Woo Lee, Yong-Won Choi, Jae Ho Han, Jang Hee Kim, Jae Ho Jung, Seong Hyun Jeong, Seok Yun Kang, Jin-Hyuk Choi, Young Taek Oh, Kwang Joo Park, Sung Chul Hwang, Seung Soo Sheen

Lung Cancer. 2009;65(3):377-382

Link1 Link2

Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer

Lung Cancer. 1995;12(3):315

Link1 Link2

66: Outcomes of patients in the North Trent region with advanced non-small-cell lung cancer treated with maintenance pemetrexed following induction with platinum non-pemetrexed doublet chemotherapy

R. Marshall, M. Kakoudaki, S.J. Danson, P.M. Fisher, M.Q. Hatton, C.E. Lee, T. Das, E. Bates, P. Woll, F. Taylor

Lung Cancer. 2017;103:S31

Link1 Link2

Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet

Emilia Kozłowska, Rafał Suwiński, Monika Giglok, Andrzej Świerniak, Marek Kimmel

PLOS Computational Biology. 2020;16(10):e1008234

Link1

Reactive Oxygen Species (ROS): Modulator of Response to Cancer Therapy in Non-Small-Cell Lung Carcinoma (NSCLC)

Shamee Bhattacharjee

Oxidative Stress in Lung Diseases. 2019;363-383

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.